Investors

Presentation

This section provides all the information and documents of interest to the financial community.

Shareholders’ space

Corporate
02/02/2026

Valbiotis expands its ValbiotisPLUS® range with the new Menopause & Perimenopause solution

Download
Finance
01/27/2026

Activity point

Download
Finance
01/26/2026

Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges

Download
Scientific
01/12/2026

A major new scientific publication on TOTUM-448

Download

Breakdown of share capital

Capital breakdown updated as of November, 27, 2025
62% of capital held by individual investors (Source: TPI, November, 27, 2025)

Financial calendar

 

Events
3
March 2025

Publication of Annual Financial Report

18
April 2025

Annual General Meeting

2
March 2026

Publication of annual results

Regulatory information

Access documents

Annual general meetings

Access documents

Financial information

 

Analysts coverage

Portzamparc*
Analysts: Mohamed Kaabouni

Invest Securities*
Analyst: Thibaut Voglimacci-Stephanopoli

TP ICAP Midcap*
Analyst: Corentin Marty

*Sponsored research